MedCity News

JUNE 16, 2023

Investors in 2022 appeared confident that the continued transformation of drug research and development protocols and the overall life sciences industry will not only include digital health solutions, but will even depend on them for data collection, analysis, patient engagement, and even their therapeutic properties.

Pharma 123

Pharma Food and Drug Administration Recruitment Patients 123

European Pharmaceutical Review

APRIL 21, 2023

In addition, the number of active substances detected in the environment has been increasing with unknown consequences for ecosystems and the accumulation of substances in food chains. Therefore, another question is how we can obtain reliable, transparent information on older drugs.

Pharma 98

Pharma Food and Drug Administration Medicine Pharmaceutical 98

Clarivate

MARCH 17, 2022

Drug developers often face a Catch-22 regarding clinical trials and pregnancy. How feasible is it to establish a drug’s safety for use in a population that may be unwilling or unable to participate in clinical trials? We look at the outcome of a recent Food and Drug Administration meeting and their draft guidance for more information.

Food and Drug Administration 10

Food and Drug Administration Safety FDA Ethics 10

PM360

NOVEMBER 21, 2024

Adam became CEO of Labcorp in 2019 and Chairman of the Board in 2020. Prior to that, he was named Lead Independent Director in 2019 after serving as a director of the company since 2013. He was Executive VP and President of Merck’s Global Human Health Division from 2010 to 2019. Food and Drug Administration (FDA) approval.

Ethics 59

Ethics Food and Drug Administration Marketing Healthcare 59

European Pharmaceutical Review

NOVEMBER 15, 2022

As ISPE GAMP 5 Second Edition notes in the preface “Operating in a highly regulated industry may lead practitioners to apply prescriptive and rigid compliance-based approaches that are not commensurate with and not effective in managing any actual risk to the product and the patient.”

Manufacturing 98

Manufacturing Pharma Food and Drug Administration Safety 98

Pharmaceutical Technology

MARCH 30, 2023

On March 29, the US Food and Drug Administration (FDA) granted approval for the first nonprescription, “over-the-counter” (OTC) naloxone nasal spray, Narcan. The overdose death rate in the US increased more than 250% from 1999 to 2019, as per a Canada-US joint white paper on substance use and harms.

Food and Drug Administration 52

Food and Drug Administration FDA Prescription Manufacturing 52

Legacy MEDSearch

JULY 6, 2023

Food and Drug Administration (FDA). This important milestone enables the world’s first prescription music platform, and is a remarkable day for our company, for music, for healthcare, and most importantly for stroke survivors.” The burden on patient functioning is also profound.

FDA 52

FDA Food and Drug Administration Recruitment Medical 52

Pharmaceutical Technology

APRIL 21, 2023

Whilst Emergent has broken through to produce a drug that reduces opioid mortality rates , experts say the company’s pricing strategy might put it out of reach for those who need it most. The overdose US death rate that has seen a 250% increase from 1999 to 2019.

Food and Drug Administration 52

Food and Drug Administration Retail Prescription Management 52

World of DTC Marketing

APRIL 7, 2022

healthcare spending during 2019 was nearly $3.8 Launch prices of new cancer drugs in the U.S. Food and Drug Administration (FDA). billion estimated cumulative spending on the new oral targeted cancer drugs by the end of 2018. from 2019 to 2020, much faster than the 4.3% increase from 2018 to 2019.

Healthcare 215

Healthcare Healthcare Food and Drug Administration Government 215